Join us as we continue our complimentary 3-part review of COVID-19 vaccine boosters. The first eLearning CPE, Pfizer-BioNTech COVID-19 Vaccine Booster Dose: Indications, Vaccine Effectiveness, and Safety, provides a framework for the ongoing research in this ever-evolving landscape. Learn about the clinical data behind the recommendation for a booster dose in specific populations, review data on Pfizer-BioNTech’s COVID-19 booster, assess risk vs benefit profiles, as well as hit on key points applicable to all currently available COVID-19 vaccines. The second home study hits on Moderna’s booster vaccine. This third installment will focus primarily on the Janssen COVID-19 vaccine’s Emergency Use Authorization to now include booster doses as of October 20, 2021. We will briefly discuss the EUA then jump right into both the literature, the FDA’s Vaccines and Related Biological Products Advisory Committee (VRBPAC) briefing materials, and highlights from the CDC’s Advisory Committee on Immunization Practices (ACIP) meeting held for Coronavirus Disease 2019 (COVID-19) Vaccines.
At the completion of this activity, the participant will be able to:
- List the population groups for which Janssen’s COVID-19 vaccine booster dose is approved for as outlined by the FDA’s EUA released on October 20, 2021.
- Discuss the clinical evidence for Janssen’s COVID-19 vaccine booster dose.
- Describe the available safety data for the Janssen booster dose.
Activity type: Knowledge-based
Target Audience: Pharmacists
The American Pharmacists Association is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. The following archived webinar is approved for 0.5 contact hours of CPE credit (0.05 CEUs). The ACPE Universal Activity Number for this activity is 0202-0000-21-388-H06-P.
To obtain credit for completing Janssen COVID-19 Vaccine Booster Dose: Vaccine Effectiveness and Safety participants will need to watch the archived webinar, complete the assessment with a grade of 70% or better, complete the evaluation questions, and then CLAIM credit. Participants need to have a valid pharmacist.com username and password to claim credit. After credit has been claimed, please visit CPE monitor for your transcript.Initial release date: November 1, 2021
Expiration date: November 1, 2023 - No credit can be claimed after this date
Janssen COVID-19 Vaccine Booster Dose: Vaccine Effectiveness and Safety is an activity for pharmacists developed by the American Pharmacists Association. © 2021 American Pharmacists Association
Dr. Kieu Nguyen and APhA’s editorial staff declare no conflicts of interest or financial interests in any product or service mentioned in this activity, including grants, employment, gifts, stock holdings, and honoraria. For a complete list of APhA staff disclosures, visit the APhA website at www.pharmacist.com/apha-disclosures.
This learning product is free to APhA members and non-members
Computer and internet access are required to complete this activity. Please visit our website to view the Technology System Requirements in order to have a positive learning experience.
|Activity Number||Credit Amount||Accreditation Period|
|ACPE# 0202-0000-21-388-H06-P||0.05 CEUs||November 01, 2021 - November 01, 2023|